“We are making a vaccine that covers omicron and all the other variants. There are so much trials that are going right now, and a lot of them we’ll start reading by the end of the month,” Pfizer CEO Albert Bourla said, adding that he’s optimistic from the preliminary data he’s seen so for.
Photo Credit: Towfiqu barbhuiya
Comments